FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2106331335> ?p ?o ?g. }

• W2106331335 endingPage "221" @default.
• W2106331335 startingPage "221" @default.
• W2106331335 abstract "Background and Objectives：Nitric oxide (NO) is thought to have antiatherosclerotic properties. On the other hand, NO activity is reduced in patients with metabolic syndrome, and endothelial dysfunction is an important early sign of atherosclerosis in patients with metabolic syndrome. The aim of this study was to investigate the effect of pioglitazone on the endothelial function in terms of the plasma NOx (combined nitrate/nitrite), the circulating inflammatory markers and the autonomic nervous system. Subjects and Methods：We randomized 40 subjects with metabolic syndrome, and they were assigned to receive 15 mg of pioglitazone per day (the PIO group, n=21) during 12 weeks or they were placed in the placebo group (the PLA group, n=19). We estimate the endothelial function by performing vascular ultrasound. The plasma NOx levels, the levels of the inflammatory markers and the GRK2 levels were measured. Results：After 12 weeks of therapy, flow mediated dilation (FMD) was improved in the PIO group (from 6.7±6% to 11.7±5%, respectively: p<0.05), but not in the PLA group. The level of plasma NOx was increased in the PIO group (from 67.7±30 nmol/dL to 92.9±41 nmol/dL, respectively: p<0.001), but not in the PLA group. The plasma levels of hsCRP and IL-6 dropped significantly (from 2.6±2.3 mg/L to 1.2±1.3 mg/L and 1.7±2.1 pg/mL to 0.7±0.5 pg/mL, respectively: p<0.05) in the PIO group, but not in the PLA group. The levels of GRK2 (the PLA group from 0.0061±0.0023 ng to 0.0075±0.0031 ng, and the PIO group from 0.0024±0.002 ng to 0.0015±0.001 ng, p=ns) didn’t dropped significantly. Conclusion：Administration of PPAR-γ agonist in patients suffering with metabolic syndrome improves their endothelial function, enhances the production of NOx and reduces the proinflammatory markers, but this is not related to sympathetic regulation. PPAR-γ agonist may be able to modulate the progression of atherosclerosis. (Korean Circulation J 2007;37:221-229)" @default.
• W2106331335 created "2016-06-24" @default.
• W2106331335 creator A5005154309 @default.
• W2106331335 creator A5010133256 @default.
• W2106331335 creator A5047235637 @default.
• W2106331335 creator A5066705825 @default.
• W2106331335 creator A5068926359 @default.
• W2106331335 creator A5076102598 @default.
• W2106331335 date "2007-01-01" @default.
• W2106331335 modified "2023-10-05" @default.
• W2106331335 title "Peroxisome Proliferator-Activated Receptor Gamma(PPAR-γ) Agonist Improves Endothelial Function in Diabetic Patients with Metabolic Syndrome: Pivotal Role of NOx and Inflammation" @default.
• W2106331335 cites W1963886325 @default.
• W2106331335 cites W1963934554 @default.
• W2106331335 cites W1967251818 @default.
• W2106331335 cites W1977386411 @default.
• W2106331335 cites W1984429122 @default.
• W2106331335 cites W1989619519 @default.
• W2106331335 cites W2003686368 @default.
• W2106331335 cites W2014663082 @default.
• W2106331335 cites W2015108783 @default.
• W2106331335 cites W2034747255 @default.
• W2106331335 cites W2034903054 @default.
• W2106331335 cites W2049316656 @default.
• W2106331335 cites W2054727930 @default.
• W2106331335 cites W2060449981 @default.
• W2106331335 cites W2065133286 @default.
• W2106331335 cites W2079635958 @default.
• W2106331335 cites W2094996190 @default.
• W2106331335 cites W2111154780 @default.
• W2106331335 cites W2113446450 @default.
• W2106331335 cites W2114164301 @default.
• W2106331335 cites W2118310760 @default.
• W2106331335 cites W2121065969 @default.
• W2106331335 cites W2121982383 @default.
• W2106331335 cites W2132594773 @default.
• W2106331335 cites W2138199798 @default.
• W2106331335 cites W2144829836 @default.
• W2106331335 cites W2152037109 @default.
• W2106331335 cites W2159316372 @default.
• W2106331335 cites W2166895394 @default.
• W2106331335 cites W2468119228 @default.
• W2106331335 cites W87082738 @default.
• W2106331335 doi "https://doi.org/10.4070/kcj.2007.37.5.221" @default.
• W2106331335 hasPublicationYear "2007" @default.
• W2106331335 type Work @default.
• W2106331335 sameAs 2106331335 @default.
• W2106331335 citedByCount "2" @default.
• W2106331335 crossrefType "journal-article" @default.
• W2106331335 hasAuthorship W2106331335A5005154309 @default.
• W2106331335 hasAuthorship W2106331335A5010133256 @default.
• W2106331335 hasAuthorship W2106331335A5047235637 @default.
• W2106331335 hasAuthorship W2106331335A5066705825 @default.
• W2106331335 hasAuthorship W2106331335A5068926359 @default.
• W2106331335 hasAuthorship W2106331335A5076102598 @default.
• W2106331335 hasConcept C105923489 @default.
• W2106331335 hasConcept C126322002 @default.
• W2106331335 hasConcept C130241916 @default.
• W2106331335 hasConcept C134018914 @default.
• W2106331335 hasConcept C14036430 @default.
• W2106331335 hasConcept C170493617 @default.
• W2106331335 hasConcept C178790620 @default.
• W2106331335 hasConcept C185592680 @default.
• W2106331335 hasConcept C187345961 @default.
• W2106331335 hasConcept C203032635 @default.
• W2106331335 hasConcept C2776914184 @default.
• W2106331335 hasConcept C2778938600 @default.
• W2106331335 hasConcept C2780578515 @default.
• W2106331335 hasConcept C555293320 @default.
• W2106331335 hasConcept C71924100 @default.
• W2106331335 hasConcept C7341990 @default.
• W2106331335 hasConcept C86803240 @default.
• W2106331335 hasConcept C95444343 @default.
• W2106331335 hasConcept C98274493 @default.
• W2106331335 hasConceptScore W2106331335C105923489 @default.
• W2106331335 hasConceptScore W2106331335C126322002 @default.
• W2106331335 hasConceptScore W2106331335C130241916 @default.
• W2106331335 hasConceptScore W2106331335C134018914 @default.
• W2106331335 hasConceptScore W2106331335C14036430 @default.
• W2106331335 hasConceptScore W2106331335C170493617 @default.
• W2106331335 hasConceptScore W2106331335C178790620 @default.
• W2106331335 hasConceptScore W2106331335C185592680 @default.
• W2106331335 hasConceptScore W2106331335C187345961 @default.
• W2106331335 hasConceptScore W2106331335C203032635 @default.
• W2106331335 hasConceptScore W2106331335C2776914184 @default.
• W2106331335 hasConceptScore W2106331335C2778938600 @default.
• W2106331335 hasConceptScore W2106331335C2780578515 @default.
• W2106331335 hasConceptScore W2106331335C555293320 @default.
• W2106331335 hasConceptScore W2106331335C71924100 @default.
• W2106331335 hasConceptScore W2106331335C7341990 @default.
• W2106331335 hasConceptScore W2106331335C86803240 @default.
• W2106331335 hasConceptScore W2106331335C95444343 @default.
• W2106331335 hasConceptScore W2106331335C98274493 @default.
• W2106331335 hasIssue "5" @default.
• W2106331335 hasLocation W21063313351 @default.
• W2106331335 hasOpenAccess W2106331335 @default.
• W2106331335 hasPrimaryLocation W21063313351 @default.
• W2106331335 hasRelatedWork W2040565048 @default.
• W2106331335 hasRelatedWork W2073807083 @default.

• next